• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight

SciDev is a leader in the development and application of both chemistry and process control for solids-liquid separation.
View the full Corporate Spotlight arrow Created with Sketch.

$4.16 MILLION

arrow-down-2 Created with Sketch.

Successful $4.16 million Capital Raising 

ASX Announcement 13 September 2019  


SciDev Ltd (ASX:SDV, SciDev or the Company) is pleased to advise that it has received binding commitments from local institutional and sophisticated investors to successfully raise gross proceeds of $4.16 million by way of a placement of new fully paid ordinary shares (“the Placement”).


The Placement was anchored by leading Australian fund manager Perennial Value Management.


The Company also welcomes the continued support from existing key institutional shareholders and other well-known Australian institutional funds that are now on the Company’s share register.


The funds from the Placement will predominantly be used to: 

  • Increase inventory to deliver into SDV’s recently announced multi-year contract with Iluka (ref ASX release 30 August 2019); 
  • Continue development of SDV’s OptiFlox® and MaxiFlox® technology in the Mining and Oil & Gas industries in North America; and 
  • Increase working capital required for the ongoing execution of existing business development opportunities both domestically and overseas.


Placement Details 

The Placement will result in the issue of 16,000,000 new fully paid ordinary shares at an issue price of $0.26 per share to raise total proceeds of $4.16 million. The issue price of $0.26 per share represents an 8.8% discount to the Company’s last traded price of $0.285. 


The Placement was oversubscribed. The 16,000,000 new shares issued represents 15% of the existing company’s shares on issue, which is the maximum number of ordinary shares that were able to be issued under ASX Listing Rule 7.1.


Settlement of the Placement is expected to occur on the 19th September 2019, with the issue and trading of the new shares expected to commence on the 20 th September.


An Appendix 3B New Issues Notice will be lodged in due course. The Company was required to issue a cleansing prospectus in order to undertake the Placement; a copy of which is attached


Commenting on the completion of the Placement, SciDev CEO, Lewis Utting said: 

“SciDev is delighted with the strong response from the institutional investment community. This milestone is a testament to the hard work from the team. I would like to thank our existing holders for their continued support, welcome the addition of some strong institutional funds on to the register and long-term holders Taylor Collision for their support. Funds received from the placement will help the company execute recent contract wins and deliver on our growing number of business development opportunities.” 


Click here to view the full announcement

SCIDEV EXPANDS

arrow-down-2 Created with Sketch.

SciDev Expands into Asian Nickel-Cobalt Operation

ASX Announcement 9 September 2019 


Highlights 

  • SciDev appointed to oversee and manage Nuoer China Chemical supplies into the Ramu Nickel-Cobalt Operation in PNG 
  • The transaction represents the first Asian nickel-cobalt exposure for SciDev and highlights the strengthening relationship with Nuoer China


SciDev Limited (ASX:SDV; SciDev, or the Company) is pleased to advise that it has been requested by cornerstone chemistry provider Nuoer China (Ref ASX: 20 May 2019 and 11 February 2019) to provide installation and oversight services at the Ramu Nickel Mine on the north-west coast of PNG, where Nuoer China will be supplying a range of chemical solutions.


SciDev technical professionals mobilised to site last week conducting several technical laboratory programmes and site processing audits. The professional services delivered by SciDev for Nuoer China demonstrates the strengthening relationship between the parties in the mineral processing field with the services set to continue during the term of the Nuoer China supply agreement.


SciDev’s strategic relationship provides opportunities for the company to engage with Chinese majority owned processing operations. These opportunities are not readily available to our competitors.


SciDev’s activities at Ramu represent its first entry into the Asian nickel-cobalt market with the Company’s unique understanding of difficult ore types and complex processing routes. The Company’s OptiFlox® technology has the potential to improve ore processing through the online evaluation of plant feed and optimising the front-end solids liquid separation processes that are critical to the success of most nickel laterite operations.


The laterite nickel processing segment is strategically relevant for SciDev and represents one of the largest chemical opportunities in the mineral processing market with large volume users in Australia, Papua New Guinea, the Philippines, New Caledonia, Madagascar and other regions.


About SciDev 

SciDev is a leader in the development and application of both chemistry and process control for solidsliquid separation. SciDev brings together world-class technology, chemistry, management and manufacturing capabilities to solve pressing operational and environmental issues for the minerals processing, tailings, water treatment and Oil & Gas markets.


About OptiFlox® 

OptiFlox® is a patent pending technology that continuously analyses and measures key parameters in industrial process streams. The OptiFlox® system improves the clarification of water, improves the addition of chemistry allowing for optimal utilisation of several industrial processes including mineral processing and water treatment.


About MaxiFlox® 

Our MaxiFlox® flocculants and coagulants are made to SciDev specification in house and by Nuoer Group and cover a broad range of conventional and advanced flocculant and coagulant products. Our MaxiFlox® proprietary technology is specifically optimised for application with our OptiFlox® control technology across most applications. It provides highly effective solution based approach at treatment costs up to 30% less than our competitors.


Click here to view the full announcement

INVESTOR PRESENTATION

arrow-down-2 Created with Sketch.

QUARTER TO DATE

arrow-down-2 Created with Sketch.

SciDev FY2020 Q1 quarter to date sales exceed AUD$1.4M

ASX Announcement 2 September 2019 


Highlights 

  • SciDev sales for the Q1 FY20 quarter to date (July & August) were AUD $1.4M representing a 40% increase on sales for the whole of Q4 FY19 
  • The increase in sales come from both growth in the oil & gas sector in addition to the realisation of new business development in the mining sector 
  • Positive customer feedback from existing contracts and recent contract wins highlights the commercial viability of SciDev’s range of proprietary process controls and chemistries for application in solid-liquid separation across a range of industries


SciDev Limited (ASX:SDV; SciDev, or the Company) is pleased to advise that it has achieved total sales of AUD$1.4M for the months of July and August 2019. The sales can be directly attributed to fifty percent of the oil & gas trial product order being invoiced during the month (refer ASX 22nd July 2019) in addition to other sales in the oil & gas sector and growth in the Australian mining sector. 


The average monthly sales revenue for July and August 2019 represents an approximate 110% increase of the average monthly sales revenue achieved in the last quarter of FY19, which was itself a record quarter for the Company. A significant portion of the sales generated from SciDev’s existing oil & gas contract is expected to be receipted in the current quarter depending on shipping schedules and timing of North America customs clearance. Sales for September are unlikely to exceed the August result.


SciDev Managing Director and CEO Lewis Utting said; “The sales outcome for Q1 so far is exceptional and I am proud of what the team has been able to achieve. We are seeing the hard work of the team over the last few quarters now convert to sales contracts with recurring revenue streams. Our near term goal of increasing our revenues with a view to becoming cashflow positive is now within reach. Considering this achievement and the recent multi-year contract agreement with Iluka, SciDev is off to an excellent start in FY20 and we look forward to further updating shareholders as the year progresses”. 


About SciDev 

SciDev is a leader in the development and application of both chemistry and process control for solidsliquid separation. SciDev brings together world-class technology, chemistry, management and manufacturing capabilities to solve pressing operational and environmental issues for the minerals processing, tailings, water treatment and Oil & Gas markets.


About OptiFlox® 

OptiFlox® is a patent pending technology that continuously analyses and measures key parameters in industrial process streams. The OptiFlox® system improves the clarification of water, improves the addition of chemistry allowing for optimal utilisation of several industrial processes including mineral processing and water treatment.


About MaxiFlox® 

Our MaxiFlox® flocculants and coagulants are made to SciDev specification in house and by Nuoer Group and cover a broad range of conventional and advanced flocculant and coagulant products. Our MaxiFlox® proprietary technology is specifically optimised for application with our OptiFlox® control technology across most applications. It provides highly effective solution based approach at treatment costs up to 30% less than our competitors.


Click here to view the full announcement

SALES CONTRACT

arrow-down-2 Created with Sketch.

SciDev awarded long term MaxiFlox® Sales Contract with Iluka Resources

ASX Announcement 30 August 2019 


Highlights 

  • SciDev and Iluka have agreed to a three year sales contract for Iluka’sflagship JacinthAmbrosia site for its MaxiFlox® chemistry 
  • Revenue to SciDev is expected to be AUD $8M – AUD $12M over the duration of the contract for supply of the MaxiFlox® chemistry 
  • The contract follows a comprehensive period of evaluation of SciDev’s technology on site by the SciDev technical team in parallel with the Company’s OptiFlox® technology


SciDev Limited (ASX:SDV; SciDev, or the Company) is delighted to advise that it has signed a three (3) year agreement for the supply and service of it’s MaxiFlox® chemistry. The annual value of the contract over the term is likely to be between AUD $2.6M – AUD $4.0M. There are no conditions precedent to the transaction.


During an extensive evaluation period on site, the company was able to build a knowledge base allowing for the design of bespoke chemistry specifically for the Jacinth Ambrosia operation.


Additional discussions are underway to integrate the SciDev OptiFlox® system into the Jacinth-Ambrosia operation.


SciDev Managing Director and CEO Lewis Utting said; “This agreement is further validation of the commercial utility of our MaxiFlox® chemistry in the mine tailings space. Just as importantly, it highlights the calibre of the SciDev team in executing the technical and commercial evaluations over an extended period with a tier one Australian mining company”. 


About SciDev 

SciDev is a leader in the development and application of both chemistry and process control for solidsliquid separation. SciDev brings together world-class technology, chemistry, management and manufacturing capabilities to solve pressing operational and environmental issues for the minerals processing, tailings, water treatment and Oil & Gas markets.


About OptiFlox® 

OptiFlox® is a patent pending technology that continuously analyses and measures key parameters in industrial process streams. The OptiFlox® system improves the clarification of water, improves the addition of chemistry allowing for optimal utilisation of several industrial processes including mineral processing and water treatment.


About MaxiFlox® 

Our MaxiFlox® flocculants and coagulants are made to SciDev specification in house by Nuoer Group and cover a broad range of conventional and advanced flocculant and coagulant products. Our MaxiFlox® proprietary technology is specifically optimised for application with our OptiFlox® control technology across most applications. It provides highly effective solution based approach at treatment costs up to 30% less than our competitors.


Click here to view the full announcement 

(20min delay)
Last
44.0¢
Change
0.025(6.02%)
Mkt cap ! $54.23M
Open High Low Value Volume
41.0¢ 45.0¢ 40.5¢ $251.1K 584.3K

Buyers (Bids)

No. Vol. Price($)
2 22383 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
44.0¢ 277744 1
View Market Depth
Last update - 16.10pm 23/09/2019 (20 minute delay) ?
(live)
Last
43.0¢
  Change
0.025 ( 4.88 %)
Open High Low Volume
41.0¢ 44.5¢ 40.5¢ 50339
Last updated 15.52pm 23/09/2019 (live) ?
SDV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.